Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fournier's disease.

R Vick1, C C Carson

  • 1Department of Urology, University of North Carolina, School of Medicine, Chapel Hill, USA.

The Urologic Clinics of North America
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Fournier's gangrene, a severe perineal infection, often has identifiable urologic or colorectal sources. Early diagnosis and aggressive treatment, including debridement and antibiotics, are crucial for improving survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Readability, credibility and quality of patient information for hypogonadism and testosterone replacement therapy on the Internet.

International journal of impotence research·2017
Same author

Tramadol for the management of premature ejaculation: a timely systematic review.

International journal of impotence research·2015
Same author

Tadalafil - a therapeutic option in the management of BPH-LUTS.

International journal of clinical practice·2013
Same author

The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.

International journal of clinical practice·2013
Same author

Impact of an educational initiative on applied knowledge and attitudes of physicians who treat sexual dysfunction.

International journal of impotence research·2008
Same author

Ejaculatory dysfunction: progress in a rarely recognized sexual problem.

International journal of impotence research·2006
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Area of Science:

  • Urology
  • Infectious Diseases
  • Dermatology

Background:

  • Fournier's gangrene is an aggressive synergistic necrotizing fasciitis affecting the perineum.
  • While historically considered idiopathic, most cases now have identifiable urologic, colorectal, or cutaneous origins.

Purpose of the Study:

  • To review the etiology, risk factors, diagnosis, and management of Fournier's gangrene.
  • To emphasize the importance of early recognition and prompt treatment to improve patient outcomes.

Main Methods:

  • Literature review of Fournier's gangrene cases and treatment modalities.
  • Analysis of risk factors, diagnostic challenges, and therapeutic strategies.

Main Results:

  • High mortality rates persist, especially in elderly patients, those with renal failure, or extensive disease.

Related Experiment Videos

  • Risk factors include diabetes, alcoholism, and immunosuppression; increasing AIDS population may raise incidence.
  • Imaging modalities aid in early diagnosis and reducing missed cases.
  • Conclusions:

    • Broad-spectrum antibiotics and aggressive surgical debridement are the cornerstones of treatment.
    • Hyperbaric oxygen therapy, advanced wound care, and reconstructive surgery can improve outcomes.
    • Early recognition, prompt intervention, and comprehensive management are key to reducing mortality and improving cosmetic results.